Upregulated circRNA ARHGAP10 Predicts an Unfavorable Prognosis in NSCLC through Regulation of the miR-150-5p/GLUT-1 Axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Upregulated circRNA ARHGAP10 Predicts an Unfavorable Prognosis in NSCLC through Regulation of the miR-150-5p/GLUT-1 Axis

Published:2019-12 Issue: Volume:18 Page:219-231
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Jin Mingming,Shi Chunzi,Yang Chen,Liu Jianjun,Huang Gang

Funder

The National Natural Science Foundation of China

Shanghai Key Laboratory of Molecular Imaging

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference32 articles.

1. Cancer statistics for Hispanics/Latinos, 2018;Miller;CA Cancer J. Clin.,2018

2. Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer;Tan;Lancet Oncol.,2015

3. Non-small-cell lung cancer;Gridelli;Nat. Rev. Dis. Primers,2015

4. Scrambled exons;Nigro;Cell,1991

5. Circular transcripts of the testis-determining gene Sry in adult mouse testis;Capel;Cell,1993

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced approaches of the use of circRNAs as a replacement for cancer therapy;Non-coding RNA Research;2024-09

2. CircZNF609 inhibits miR-150-5p to promote high glucose-induced damage to retinal microvascular endothelial cells;Molecular and Cellular Endocrinology;2024-09

3. The functional significance of circRNA/miRNA/mRNA interactions as a regulatory network in lung cancer biology;The International Journal of Biochemistry & Cell Biology;2024-04

4. Hsa_circ_0008133 contributes to lung cancer progression by promoting glycolysis metabolism through the miR‐760/MEX3A axis;Environmental Toxicology;2024-02-05

5. Sevoflurane inhibits the malignant behavior of nasopharyngeal carcinoma cells by regulating mitochondrial membrane potential;General physiology and biophysics;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3